TARA Stock: Protara Therapeutics, Inc. Stock Price, Analysis & Insights
Get live tara stock price $6.75, comprehensive Protara Therapeutics, Inc. stock analysis, charts, news, and expert forecast. Real-time tara stock data and investment insights.
Loading chart...
Company Overview
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is headquartered in New York, New York.
Company Information
- CEO
- Jesse Shefferman
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 28
Contact Information
- Website
- https://www.protaratx.com
- Address
- 345 Park Avenue South
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 1.43)
Business Model & Strategy
Protara Therapeutics, Inc. operates in the Biotechnology industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Jesse Shefferman, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Biotechnology model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Protara Therapeutics, Inc. competes in the Biotechnology within the broader Healthcare. With 260.5 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Global Market, Protara Therapeutics, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Protara Therapeutics, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Protara Therapeutics, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Protara Therapeutics, Inc.
- ⚠Investors should consider how Protara Therapeutics, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
260.46M
P/E Ratio
-4.86
Beta
1.43
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 260.46M market capitalization
- Trading Volume: 1.63M shares traded today
- Price Range: 52-week range of $2.28 - $10.48
- Exchange: Listed on NASDAQ Global Market
Financial Metrics
Market Analysis for Protara Therapeutics, Inc.
Protara Therapeutics, Inc. (TARA) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 260.46M, the company represents a significant player in its market. The stock is currently trading at $6.75 with a positivedaily change of 21.18%.
The company's 28 employee base and presence on the NASDAQ Global Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -4.86, beta of 1.43, and 52-week price range from $2.28 to $10.48when evaluating investment opportunities.
Why Invest in Protara Therapeutics, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Market)
- • Experienced leadership under Jesse Shefferman
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.